RSV immunity study for Aboriginal and Torres Strait Islander babies
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This study tests whether giving a special antibody medicine (called RSV-SMA) to babies aged 6–9 months can help prevent respiratory syncytial virus (RSV), a common virus that causes serious breathing problems in young children. Your baby would receive the medicine and be followed to see if it helps protect them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is Aboriginal and/or Torres Strait Islander
- Your baby is between 6 and 9 months old
- You are willing to give informed consent for your baby to participate
- You can follow all study visits and allow the study team to review your baby's medical records and vaccination history
- Your baby has not had a severe allergic reaction (anaphylaxis) to RSV-SMA before
- Your baby has not received RSV-SMA at 3 months of age or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how your body's immune system responds to a new respiratory syncytial virus (RSV) vaccine. RSV is a common virus that causes respiratory infections, especially in older adults. The vaccine may help protect you from RSV disease.
This trial tests a new vaccine (MKK900) to see if it is safe and works well in healthy adult women. It is designed to protect against RSV, a common virus that can be serious in newborns and older adults. The vaccine is being developed for use during pregnancy to pass protection to babies.
This trial tests a new medicine called SIBP-A16 to help protect infants from RSV, a common virus that can cause serious breathing problems. It is for preterm and full-term infants under 1 year old who are entering their first RSV season.
This trial studies whether giving a booster dose of the RSV vaccine (Abrysvo) is safe and effective for adults with weakened immune systems. It includes people who have never had an RSV vaccine and those who had one or two doses in the past.
This study watches infants in Brazil who are hospitalized or visit a clinic with breathing problems to see if their mother's RSV vaccine helped protect them. It may help doctors understand how well the vaccine works in real life.
This study asks parents in Queensland about their infant's RSV (respiratory syncytial virus) vaccination status and experiences. RSV is a common virus that can cause serious breathing problems in babies, and this research helps understand vaccination patterns.
Hear when a new Respiratory Syncytial Virus (RSV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.